4.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Vistagen Therapeutics Inc Borsa (VTGN) Ultime notizie
Vistagen Therapeutics Inc Stock Analysis and ForecastValue Traps to Avoid & Market Crushing Stock Picks - earlytimes.in
Tools to assess Vistagen Therapeutics Inc.’s risk profile2025 Sector Review & AI Based Buy/Sell Signal Reports - newser.com
Combining machine learning predictions for Vistagen Therapeutics Inc.2025 Growth vs Value & Free Community Supported Trade Ideas - newser.com
Vistagen Therapeutics Inc. stock momentum explained2025 Investor Takeaways & Low Volatility Stock Recommendations - newser.com
Vistagen to Present at The Menopause Society 2025 Annual Meeting - Stock Titan
Applying Elliott Wave Theory to Vistagen Therapeutics Inc.Trend Reversal & Low Risk Entry Point Guides - newser.com
Will Vistagen Therapeutics Inc. stock gain from strong economyMarket Movement Recap & Expert Approved Momentum Ideas - newser.com
What institutional flow reveals about Vistagen Therapeutics Inc.July 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
How to recover losses in Vistagen Therapeutics Inc. stockPortfolio Return Report & Free Technical Confirmation Trade Alerts - newser.com
Vistagen Therapeutics, Inc.Common Stock (NQ: VTGN - FinancialContent
VistaGen Therapeutics’ (VTGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World
Published on: 2025-10-10 09:33:10 - newser.com
Using Ichimoku Cloud for Vistagen Therapeutics Inc. technicalsExit Point & Intraday High Probability Setup Alerts - newser.com
Published on: 2025-10-10 04:25:39 - newser.com
VistaGen Therapeutics (NASDAQ:VTGN) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat
What MACD and RSI say about Vistagen Therapeutics Inc.July 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com
We Think Vistagen Therapeutics (NASDAQ:VTGN) Needs To Drive Business Growth Carefully - Sahm
Advanced analytics toolkit walkthrough for Vistagen Therapeutics Inc.July 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com
High Stakes Ahead: Vistagen's Fasedienol Trials Could Make Or Break The Story - RTTNews
Sector ETF performance correlation with Vistagen Therapeutics Inc.July 2025 Closing Moves & High Yield Stock Recommendations - newser.com
How moving averages guide Vistagen Therapeutics Inc. trading2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com
Detecting price anomalies in Vistagen Therapeutics Inc. with AIMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com
Has Vistagen Therapeutics Inc. found a price floorJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com
Understanding Vistagen Therapeutics Inc.’s price movement2025 Top Decliners & Verified Stock Trade Ideas - newser.com
Full technical analysis of Vistagen Therapeutics Inc. stockJuly 2025 Setups & Entry and Exit Point Strategies - newser.com
Vistagen Therapeutics Inc. stock daily chart insightsJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com
What’s the recovery path for long term holders of Vistagen Therapeutics Inc.Share Buyback & Verified Momentum Stock Watchlist - newser.com
How high can Vistagen Therapeutics Inc. stock go2025 Market Sentiment & Free Safe Capital Growth Stock Tips - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):